Table 1. Rapid-quench rates of nicotinamide and deacylated product formation.
Nicotinamide formeition rate, k5 (s−1) | ||||
---|---|---|---|---|
Acetyl | Hexanoyl | Decanoyl | Myristoyl | |
SIRT2 | 1.6 ± 3×10−1 | 2.9×10−1 ± 3×10−2 | 4.3×10−1 ± 6×10−2 | 9×10−1 ± 2×10−1 |
SIRT3 | 3.8 ± 6×10−1 | 2.8×10−1 ± 5×10−2 | 4.0×10−1 ± 4×10−2 | 7.6×10−1 ± 6×10−2 |
SIRT6 | N.D. | 4.4×10−3 ± 6×10−4 | 7.3×10−2 ± 8×10−3 | 1.4×10−1 ± 2×10−2 |
Deacylated peptide formation rate, k9 (s−1) | ||||
---|---|---|---|---|
Acetyl | Hexanoyl | Decanoyl | Myristoyl | |
SIRT2 | 5.3×10−1 ± 6×10−2 | 1.1×10−1 ± 1×102 | 9.0×10−2 ± 8×10−3 | 5.3×10−2 ± 5×10−3 |
SIRT3 | 6.5×10−1 ± 2×10−2 | 8×10−2 ± 1×10−2 | 1.0×10−1 ± 1×10−2 | 6.5×10−2 ± 6×10−3 |
SIRT6 | N.D. | 2.3×10−3 ± 1×10−4 | 3.3×10−2 ± 3×10−3 | 4.2×10−2 ± 4×10−3 |